Navigation Links
vRad Goes Live with Visage 7
Date:11/21/2013

San Diego, CA (PRWEB) November 21, 2013

First US health system begins using vRad’s RG2 platform leveraging Visage 7 for primary interpretation

Visage Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), announced today that its Visage® 7 Enterprise Imaging Platform has been successfully implemented as part of RG2(SM), vRad’s next-generation radiology operational management solution. RG2—or Radiology Group 2.0—optimizes coverage of both onsite and cloud based radiology services using physician productivity tools such as a next-generation radiology reading platform with Visage’s enterprise diagnostic viewer, global worklists and advanced analytics for faster and better decision making.

vRad (Virtual Radiologic), based in Minneapolis, Minnesota, USA, is the country’s largest radiology group and telemedicine platform. vRad works in partnership with local radiology groups and hospitals to optimize radiology’s pivotal role in patient care. vRad’s more than 450 radiologists serve over 2,000 radiology groups, hospitals and health systems, reading in excess of 7 million studies annually.

“This is an important milestone for us,” said Dr. Sam Hupert, Chief Executive Officer, Visage Imaging and Pro Medicus CEO. “Our technology has proven its capability with a partner operating in a high-volume, high-demand healthcare environment. Not only does it provide vRad radiologists with the most comprehensive set of clinical tools in a single product, but it is also exceptionally fast. Unlike others who have to move ever increasing datasets across the network, we are able to instantly stream the images to radiologists’ desktops regardless of the size of the examination they are reading. Faster delivery means faster diagnoses. That’s a competitive advantage and a critical benefit for the patient communities we serve with our partners.”

“We are extremely pleased with the results of our first go live with Visage,” said Jordan Halter, vRad’s Vice President of Solutions. “RG2 is command central for ground and cloud-based radiology. It’s the future of radiology available today and Visage technology is core to delivering on the promise of ‘read anything, anywhere, anytime.’”

Under the terms of the previously announced agreement, the five-year contract period commences with the first clinical go live, paving the way for further Visage installations within vRad’s extensive national US-based network. “This is a great start for Visage and we are looking forward to further success as vRad continues to roll out its next-generation RG2 platform,” said Dr. Hupert. “We know Visage 7 will provide vRad with a significant strategic advantage in this highly competitive radiology market.”

To easily schedule a priority demonstration and/or meeting at the upcoming RSNA 2013, please visit our new website for additional details.

About Visage Imaging, Inc.

Visage Imaging is a global provider of enterprise imaging and advanced visualization solutions for diagnostic imaging. Visage 7 delivers amazingly fast server-side rendered images streamed via an intelligent thin-client viewer. Radiologists and referring physicians have a customized, protocol-driven workflow to natively view 2D, 3D, 4D and advanced visualization imagery across a single desktop. Powerful imaging solutions include enterprise viewing and interpretation; image enablement of EMRs, VNAs, HIEs and portals; RIS/PACS, as well as anywhere mobile access. http://www.visageimaging.com

About Pro Medicus Limited

Pro Medicus Limited (ASX: PME) is Australia’s leading medical IT and e-health provider. Founded in 1983, the company provides a full range of integrated software products and services to hospital, imaging centers and health care groups worldwide. http://www.promedicus.com

Read the full story at http://www.prweb.com/releases/2013/11/prweb11357598.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Mobile Imaging Access Leaps Ahead with Visage Ease
2. Visage Sculpture, Non-Surgical Face Shaping Cosmetic Practice of Boston, Announces Using Microcannulas to Make Non-Surgical Rhinoplasty Safer
3. Non-surgical Facelift, Specialty of Masha Banar PA-C of Visage Sculpture, Got a "Lift": Retrospective Comparison of Radiesse, Sculptra, and Perlane
4. Masha Banar, PA-C of Visage Sculpture, Non-surgical Face Shaping Cosmetic Practice of Boston, Confirms Resistance Forming to Botox over Time, Less to Dysport.
5. Visage Sculpture, Premiere Cosmetic Clinic of Boston, Reports Shorter-lasting Results of Fillers in Athletes and Offers a Solution
6. VISN23 Selects Visage 7 for Enterprise Imaging
7. Enterprise Imaging Speeds Ahead with Visage 7
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... 10 Best Water is excited to ... water brand owners that topped the list as a result of their commitment to ... premier brand was Tibet 5100, a top notch water company that specializes in providing ...
(Date:2/10/2016)... ... February 10, 2016 , ... Intalere’s 2016 ... more than 200 of the country’s top healthcare executives to share insights on ... benefit of the Forum is the provider-centric perspective, experience, expertise and strategy shared ...
(Date:2/10/2016)... ... February 10, 2016 , ... Armune BioScience ... across their network of laboratory service centers across the country. Launched in April of ... in the detection of prostate cancer. Apifiny order volume exceeded 3,000 tests in 2015. ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... the Ohio Safety Congress and Expo event March 9-11, 2016. Hosted by Ohio's ... Convention Center. , As the longest running and largest worker's compensation event ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... February 26th: Amateur & Professional Divisions - Time: 7:00pm – 10:00pm | ... | Ticket Prices $30, Social Media: http://www.USPoleSportsFed.org , Facebook: http://www.facebook.com/uspolesportsfederation ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)...  Resolve Therapeutics, LLC, a clinical stage biopharmaceutical ... treatment of lupus and Sjogrens syndrome, today announced ... study in patients with systemic lupus erythematosus (SLE) ... --> --> Data from a ... of RSLV-132 in 32 subjects with SLE demonstrate ...
(Date:2/10/2016)... 2016 Immune Pharmaceuticals Inc. (NASDAQ: IMNP ... it has filed a patent application directed to the ... --> --> The new ... Ceplene (histamine dihydrochloride) in combination with immune checkpoint inhibitors. ... efficacy of Ceplene and IL-2 therapy in patients with ...
(Date:2/10/2016)... A Worldwide Clinical Trials expert will present at ... Plaza in London , 24-25 February 2016. ... advances for late phase research on Wednesday, 24 Feb at ... director of project management at Worldwide, will focus on how ... standards in late phase research. --> ...
Breaking Medicine Technology: